You are here
Grant approvals committee
Funding for Eritrea, Eswatini, Kyrgyz Republic and Sudan for malaria and TB/HIV
Funding revisions to nine grants from Bhutan, Niger, South Sudan, Tanzania, Turkmenistan
On 27 September 2019, by electronic vote, the Global Fund Board approved funding for interventions from the Register of Unfunded Quality Demand (UQD) valued at $46.4 million for nine grants in five countries (see Table). Most of the funds for these awards come from a portfolio-optimization exercise that was carried out in April 2019 for the 2017-2019 allocation cycle.
Board approves a consolidated TB and malaria grant worth $42 million, from the 2017-2019 allocations
When the Global Fund terminated its grants to the Democratic People’s Republic of Korea (DPRK), also known as North Korea, on 21 February 2018, the Fund said, “We remain committed to supporting the health of the people in DPRK, and hope to re-engage when possible.”
Virtually all of $20 million set aside for emergencies has been awarded
As of 1 July 2019, the Technical Review Panel (TRP) has completed its reviews of funding requests for the 2017-2019 allocations and has issued recommendations covering all of the funds available for country allocation ($10.3 billion); all of the matching funds that were subject to TRP review ($313 million); and all of the funds earmarked for multi-country grants ($260 million).
Interventions from the UQD Register worth $42.2 million also approved
On 16 August 2019, by electronic vote, the Global Fund Board approved funding for three country grants worth $32.7 million (Colombia HIV, Honduras TB/HIV and Kazakhstan TB). Domestic commitments for the programs included in the approved country grants amounted to $1.17 billion. Initiatives valued at $2.4 million were added to the Unfunded Quality Demand (UQD) Register. (See Table 1.)
A private sector contribution of $2 million will support RAI grant in Southeast Asia; others through portfolio optimization
On 24 July 2019, the Global Fund Board approved funding in the amount of $18.0 million from the 2017-2019 allocations for several interventions on the Unfunded Quality Demand (UQD) Register. The funds will be added to three existing country grants and one existing multi-country grant. The sources of these funds are portfolio optimization and a private sector contribution. (See Table 1 below.)
Loan ‘buy-down’ leverages increased resources to frontload India’s investment, help achieve impact quickly
The Global Fund describes the $41.6 million in funding awarded to India in April as an innovative approach that will catalyze significant additional funding for the fight against tuberculosis. The award includes $40.0 million to buy down a portion of a $400.0-million loan from the World Bank over five years.
Global Fund Board approves new country and multi-country grants along with interventions on UQD Register
Largest single award was $13.2 million for a Burkina Faso malaria grant
On 13 May 2019, the Global Fund Board approved, by electronic vote, funding for five country grants having a total value of $25.2 million. Domestic commitments for the programs included in the approved country grants amounted to $937.9 million. The five country grants were for four countries: Gabon, Georgia, Peru and Serbia. The largest award ($9.3 million) was for a Georgia HIV grant. (See Table 1 for details.)
Transition to the new arrangements will happen in the first six months of 2019
New implementation arrangements have been put in place for the TB programs funded through Nigeria’s new TB and TB/HIV grants.
The Global Fund seeks the right balance between risk mitigation and grant implementation in Mali malaria grant
Because of Mali’s extreme malaria burden, its grant portfolio has been designated “high impact”
When it recommended a Mali malaria grant for approval recently, the Global Fund’s Grant Approvals Committee (GAC) acknowledged that there are implementation challenges associated with this grant and said that it welcomed the Secretariat’s plans “to identify bottlenecks, and holistically review and harmonize the controls in place with the aim of balancing risk mitigation and effective grant implementation.”